The 2021 AI Index report is one of the most comprehensive reports about artificial intelligence to date. This latest edition significantly expands the amount of data available in the report, which was drawn from a broader set of academic, private, and non-profit organizations for calibration. The report also shows the effect of COVID-19 on AI development from multiple perspectives, including how AI helps with COVID-related drug discovery and the effect of the pandemic on hiring and private investment.
This year we significantly expanded the amount of data available in the report, worked with a broader set of external organizations to calibrate our data, and deepened our connections with Stanford HAI.
The 2021 report also shows the effects of COVID-19 on AI development from multiple perspectives. The Technical Performance chapter discusses how an AI startup used machine-learning-based techniques to accelerate COVID-related drug discovery during the pandemic, and our Economy chapter suggests that AI hiring and private investment were not significantly adversely influenced by the pandemic, as both grew during 2020. If anything, COVID-19 may have led to a higher number of people participating in AI research conferences, as the pandemic forced conferences to shift to virtual formats, which in turn led to significant spikes in attendance.